PeptideNerds

ARA-290

Healing & Recovery Research Only moderate evidence Track This Protocol
Alejandro Reyes

Written by Alejandro Reyes

Founder & Lead Researcher

PN

Reviewed by Peptide Nerds Editorial · Updated April 2026

Key Takeaway

ARA-290 is a non-erythropoietic peptide derived from erythropoietin (EPO) that provides tissue protection and repair without stimulating red blood cell production.

Quick Facts
Type Healing & Recovery
FDA Status Research Only
Evidence Level Moderate
Typical Dose 4 mg daily
Frequency Once daily
Key Goals healing

How it works

Activates the innate repair receptor (IRR) to promote tissue protection, reduce inflammation, and support nerve repair.

Benefits

  • Neuroprotection
  • Anti-inflammatory
  • Tissue repair without EPO effects

Side effects

  • Well-tolerated in clinical studies
  • Mild injection site reactions

Dosing protocol

Typical Dose

4 mg daily

Frequency

Once daily

Has been studied in human clinical trials for diabetic neuropathy.

Deeper on ARA-290

Full breakdowns of every part of the ARA-290 research base.

What you will need

Basic supplies for reconstitution and subcutaneous injection.

This page contains affiliate links. Learn more

Get the ARA-290 cheat sheet

Dosing quick-reference, key studies, and side effect management — in your inbox.

Get the ARA-290 cheat sheet

Dosing quick-reference, key studies, and side effect management — in your inbox.

Related peptides

Looking for weight loss peptides? See our complete guide to the best peptides for weight loss or compare semaglutide vs tirzepatide .

Get the Peptide Starter Kit (free)

Quick-start guide to GLP-1 peptides, dosing basics, and what to ask your doctor.

Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional medical consultation, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol.